Hanson & Doremus Investment Management Viatris Inc Transaction History
Hanson & Doremus Investment Management
- $748 Million
- Q2 2025
A detailed history of Hanson & Doremus Investment Management transactions in Viatris Inc stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 100 shares of VTRS stock, worth $939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$939% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding VTRS
# of Institutions
1,125Shares Held
941MCall Options Held
4.05MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$870 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$699 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$610 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$577 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...